You are here: home > team
Logo SFB-F44

SFB-F44 - Cell signaling in chronic CNS disorders

Curriculum Vitae Jörg Striessnig

Academic Education

1969 – 1977

Akademisches Gymnasium Innsbruck

1977 - 1982

Medical School, University of Innsbruck

Career History


Internship, Internal Medicine; University Hospital Innsbruck

1984 - 1989

University Assistant (postdoc), Department of Biochemical Pharmacology, Medical School, University of Innsbruck, Austria

1989 - 1991

Visiting Assistant Professor, Department of Pharmacology, University of Washington, Seattle, USA

1991 - 1998

Assistant Professor, Department of Biochemical Pharmacology, University of Innsbruck

1998 -2001

Associate Professor, Department of Biochemical Pharmacology, University of Innsbruck

2001 - present

Full Professor and Chairman of the Department of Pharmacology and Toxicology, Institute of Pharmacy, Natural Sciences Faculty, University of Innsbruck, Austria

Awards and honors


Science award of the Ärztekammern für Tirol und Vorarlberg (1988)


Max-Kade Fellowship from the Austrian Academy of Sciences


Science award from the City of Innsbruck


International Albrecht Fleckenstein Award

1997 - 2002

Co-awards: HOECHST awards (1997, 1998, 2000), Wulf-Vater-Dihydropyridine-Award (1998), Science Award from the City of Innsbruck (2002)


Corresponding member of the Austrian Academy of Sciences


Member of the German Academy of Sciences Leopoldina


  • 107 original publications
  • 43 reviews/books
  • 33 invited symposium and conference lectures

Review panels


Ad hoc referee: J. Biol. Chem,. J. Neurosci., EMBO J, J. Cell. Physiol., J. Physiol., PNAS, Neuroscience, J. Clin. Invest., Trends Neurosci., Pharmacogenetics, Eur. J. Neurosci., Epilepsia, Brain Res., Biophys. J., FASEB J., Nat. Cell Biol., Trends. Mol. Med., J Gen Physiol, Mol. Pharmacol., J. Cell. Physiol., Hum. Mol. Genet., Gene, Exp. Gerontol., Biochemistry, BBA, Am. J. Physiol., Brit. J. Pharmacol., Mol. Neurobiol., Mol. Brain. Res.


MRC, Wellcome Trust, Austrian National Bank, National Science Foundation (USA), Human Frontier Science Programme, Biomedical Research Council Singapore

Editorial Boards:

Frontiers in Pharmacology of Ion channels and Channelopathies (Associate Editor); Channels (Editorial Board)